Apotex Pty Ltd v AstraZeneca AB (No 4)
| Jurisdiction | Australia Federal only |
| Neutral Citation | 2013-0305 FCA B |
| Date | 2013 |
| Court | Federal Court |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
8 cases
- Spirit Pharmaceuticals Pty Ltd v Mundipharma Pty Ltd
-
GM Global Technology Operations LLC v S.S.S. Auto Parts Pty Ltd
...51AB, 51AC, 52 Cases cited: ACCC v Coles Supermarkets Australia Pty Ltd [2014] FCA 634; 317 ALR 73 Apotex Pty Ltd v AstraZeneca AB (No 4) [2013] FCA 162; (2013) 100 IPR 285 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50; (2013) 253 CLR 284 Aristocrat Technologies Australia ......
-
Sequenom, Inc. v Ariosa Diagnostics, Inc.
...618 Apotex Pty Ltd (formerly GenRx Pty Ltd) v Sanofi-Aventis (2008) 78 IPR 485 Apotex Pty Ltd v AstraZeneca AB (No 4) (2013) 100 IPR 285; [2013] FCA 162 Apotex Pty Ltd v Les Laboratories Servier [2013] FCA 1426 Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (2013) 253 CLR 284 Apotex Pty ......
-
ViiV Healthcare Company v Gilead Sciences Pty Limited (No 2)
...92 IPR 46; [2011] FCA 452 at [296] per Kenny J). And as Jagot J accepted in Apotex Pty Ltd v AstraZeneca AB (No 4) (2013) 100 IPR 285; [2013] FCA 162 at [352], “[u]ltimately, an asserted lack of utility must be established by appropriate evidence, not by mere speculation that the invention ......
Request a trial to view additional results
1 firm's commentaries
-
Federal Court delivers significant judgment allowing launch of generic CRESTOR (rosuvastatin)
...similarly, it was not inventive to add a coating. A copy of Jagot J's decision can be found here: Apotex Pty Ltd v AstraZeneca AB (No 4) [2013] FCA 162. The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your sp......